{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:57:38Z","timestamp":1792195058375,"version":"4.4.0"},"reference-count":343,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The gut-liver axis describes the physiological interplay between the gut and the liver and has important implications for the maintenance of health. Disruptions of this equilibrium are an important factor in the evolution and progression of many liver diseases. The composition of the gut microbiome, the gut barrier, bacterial translocation, and bile acid metabolism are the key features of this cycle. Chronic cholestatic liver diseases include primary sclerosing cholangitis, the generic term secondary sclerosing cholangitis implying the disease secondary sclerosing cholangitis in critically ill patients and primary biliary cirrhosis. Pathophysiology of these diseases is not fully understood but seems to be multifactorial. Knowledge about the alterations of the gut-liver axis influencing the pathogenesis and the outcome of these diseases has considerably increased. Therefore, this review aims to describe the function of the healthy gut-liver axis and to sum up the pathological changes in these cholestatic liver diseases. The review compromises the actual level of knowledge about the gut microbiome (including the mycobiome and the virome), the gut barrier and the consequences of increased gut permeability, the effects of bacterial translocation, and the influence of bile acid composition and pool size in chronic cholestatic liver diseases. Furthermore, therapeutic implications and future scientific objectives are outlined.<\/jats:p>","DOI":"10.3390\/nu13031018","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T23:47:41Z","timestamp":1616370461000},"page":"1018","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["The Gut-Liver Axis in Cholestatic Liver Diseases"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-4140","authenticated-orcid":false,"given":"Andreas","family":"Blesl","sequence":"first","affiliation":[{"name":"Division for Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5508-8271","authenticated-orcid":false,"given":"Vanessa","family":"Stadlbauer","sequence":"additional","affiliation":[{"name":"Division for Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"},{"name":"Center for Biomarker Research in Medicine (CBmed), 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/cld.894","article-title":"The Pathophysiology of Cholestasis and Its Relevance to Clinical Practice","volume":"15","author":"Onofrio","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.mayocp.2020.01.015","article-title":"Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists","volume":"95","author":"Hilscher","year":"2020","journal-title":"Mayo. Clin. Proc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11894-017-0583-8","article-title":"Secondary Sclerosing Cholangitis: A Review of Recent Literature","volume":"19","author":"Brooling","year":"2017","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-010818-021059","article-title":"Drug Therapies for Chronic Cholestatic Liver Diseases","volume":"60","author":"Wagner","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2020.0028","article-title":"Current understanding of primary biliary cholangitis","volume":"27","author":"Tanaka","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.31311","article-title":"The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications","volume":"72","author":"Dean","year":"2020","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000450906","article-title":"Role of the Intestinal Microbiome in Cholestatic Liver Disease","volume":"35","author":"LaRusso","year":"2017","journal-title":"Dig. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cld.902","article-title":"Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management","volume":"15","author":"Gochanour","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/liv.13979","article-title":"Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis","volume":"39","author":"Dhillon","year":"2018","journal-title":"Liver Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CEG.S115518","article-title":"Secondary sclerosing cholangitis in critically ill patients: Current perspectives","volume":"10","author":"Gudnason","year":"2017","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000431031","article-title":"Update on Sclerosing Cholangitis in Critically Ill Patients","volume":"31","author":"Kirchner","year":"2015","journal-title":"Visc. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00365521.2010.537683","article-title":"Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation","volume":"46","author":"Kirchner","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3748\/wjg.v11.i27.4199","article-title":"Sclerosing cholangitis following severe trauma: Description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms","volume":"11","author":"Benninger","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Blesl, A., J\u00fcngst, C., Lammert, F., Fauler, G., Rainer, F., Leber, B., Feldbacher, N., Stromberger, S., Wildburger, R., and Spindelb\u00f6ck, W. (2020). Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut\u2013Liver Axis: A Case Control Study. Nutrients, 12.","DOI":"10.3390\/nu12092728"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOG.0000000000000507","article-title":"The genetics of primary biliary cholangitis","volume":"35","author":"Tanaka","year":"2019","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.25.2.133","article-title":"Bacteriuria and primary biliary cirrhosis","volume":"25","author":"Burroughs","year":"1984","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0036-1594006","article-title":"Primary Biliary Cirrhosis and the Microbiome","volume":"36","author":"Quigley","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.3748\/wjg.v18.i35.4855","article-title":"Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?","volume":"18","author":"Smyk","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajg.2013.05.006","article-title":"Anti-mitochondrial antibody positive autoimmune hepatitis triggered by EBV infection in a young girl","volume":"14","author":"Saadah","year":"2013","journal-title":"Arab. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/039463201002300431","article-title":"Celiac Disease, Primary Biliary Cirrhosis and Helicobacter Pylori Infection: One Link for Three Diseases","volume":"23","author":"Abenavoli","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/liv.14153","article-title":"The gut microbial influence on cholestatic liver disease","volume":"39","author":"Kummen","year":"2019","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kanmani, P., Suganya, K., and Kim, H. (2020). The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases. Biomedicines, 8.","DOI":"10.3390\/biomedicines8110501"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Maroni, L., Ninfole, E., Pinto, C., Benedetti, A., and Marzioni, M. (2020). Gut\u2013Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology. Cells, 9.","DOI":"10.3390\/cells9030736"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3350\/cmh.2020.0129","article-title":"The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease","volume":"27","author":"Jennison","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1471-0528.13601","article-title":"Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: A prospective cohort study","volume":"123","author":"Azad","year":"2015","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0035-1571276","article-title":"Targeting Dysbiosis for the Treatment of Liver Disease","volume":"36","author":"Anand","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0036-1593882","article-title":"Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease","volume":"36","author":"Schnabl","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","article-title":"Bile Acid Signaling in Inflammatory Bowel Diseases","volume":"66","author":"Fiorucci","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","article-title":"Emerging roles of bile acids in mucosal immunity and inflammation","volume":"12","author":"Chen","year":"2019","journal-title":"Mucosal Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Sayin","year":"2016","journal-title":"Cell Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"Tarling","year":"2013","journal-title":"Cell Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nri3228","article-title":"Epithelial antimicrobial defence of the skin and intestine","volume":"12","author":"Gallo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nri2707","article-title":"Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function","volume":"10","author":"Abreu","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA\u2019s complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_45","first-page":"171","article-title":"Acetaldehyde-induced Barrier Disruption and Paracellular Permeability in Caco-2 Cell Monolayer","volume":"447","author":"Rao","year":"2008","journal-title":"Breast Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Elinav","year":"2012","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bbi.2012.04.001","article-title":"Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects","volume":"26","author":"Leclercq","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/gutjnl-2012-304119","article-title":"Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation","volume":"63","author":"Denizot","year":"2014","journal-title":"Gut"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3892\/mmr.2014.2126","article-title":"Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins","volume":"9","author":"Wang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tulstrup, M.V.-L., Christensen, E.G., Carvalho, V., Linninge, C., Ahrn\u00e9, S., H\u00f8jberg, O., Licht, T.R., and Bahl, M.I. (2015). Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144854"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Ran, Y., Fukui, H., Xu, X., Wang, X., Ebisutani, N., Tanaka, Y., Maeda, A., Makizaki, Y., Ohno, H., and Kondo, T. (2020). Alteration of Colonic Mucosal Permeability during Antibiotic-Induced Dysbiosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176108"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"109288","DOI":"10.1016\/j.foodres.2020.109288","article-title":"Stachyose increases intestinal barrier through Akkermansia muciniphila and reduces gut inflammation in germ-free mice after human fecal transplantation","volume":"137","author":"Xi","year":"2020","journal-title":"Food Res. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"043620","DOI":"10.1242\/dmm.043620","article-title":"Akkermansia muciniphila promotes type H vessel formation and bone fracture healing by reducing gut permeability and inflammation","volume":"13","author":"Liu","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Meng, X., Wang, W., Lan, T., Yang, W., Yu, D., Fang, X., and Wu, H. (2019). A Purified Aspartic Protease from Akkermansia muciniphila Plays an Important Role in Degrading Muc2. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010072"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: The expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2008.08.096","article-title":"Role of TLR9 in hepatic stellate cells and experimental liver fibrosis","volume":"376","author":"Dorn","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_59","first-page":"G1318","article-title":"LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice","volume":"290","author":"Isayama","year":"2006","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","article-title":"Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency","volume":"140","author":"Spencer","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3945\/an.114.007955","article-title":"Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes","volume":"7","author":"Sherriff","year":"2016","journal-title":"Adv. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.gastro.2014.09.014","article-title":"Supplementation of Saturated Long-Chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice","volume":"148","author":"Chen","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Plaza-D\u00edaz, J., Sol\u00eds-Urra, P., Rodr\u00edguez-Rodr\u00edguez, F., Olivares-Arancibia, J., Navarro-Oliveros, M., Abad\u00eda-Molina, F., and \u00c1lvarez-Mercado, A. (2020). The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218351"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jhep.2014.04.015","article-title":"Bacterial translocation in liver cirrhosis: Site and role in fibrogenesis","volume":"61","author":"Matuchansky","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101636","DOI":"10.1016\/j.bpg.2019.101636","article-title":"Tests of intestinal mucosal hyperpermeability: Many diseases, many biomarkers and a bright future","volume":"40\u201341","author":"Webb","year":"2019","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1113\/jphysiol.1977.sp011750","article-title":"Increase in human intestinal permeability following ingestion of hypertonic solutions","volume":"265","author":"Laker","year":"1977","journal-title":"J. Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/cs0600115","article-title":"Passive Permeability in Experimental Intestinal Damage in Rats","volume":"60","author":"Cobden","year":"1981","journal-title":"Clin. Sci."},{"key":"ref_71","first-page":"G171","article-title":"Homeostasis of the gut barrier and potential biomarkers","volume":"312","author":"Wells","year":"2017","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-016-0089-7","article-title":"The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity","volume":"13","author":"Lau","year":"2016","journal-title":"Nutr. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bpg.2017.01.004","article-title":"Serological markers for human intestinal ischemia: A systematic review","volume":"31","author":"Derikx","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40279-020-01348-y","article-title":"The Effects of Exercise on Indirect Markers of Gut Damage and Permeability: A Systematic Review and Meta-analysis","volume":"51","author":"Chantler","year":"2021","journal-title":"Sports Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Pietrzak, B., Tomela, K., Olejnik-Schmidt, A., Mackiewicz, A., and Schmidt, M. (2020). Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239254"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3920\/BM2012.0024","article-title":"Gate-keeper function of the intestinal epithelium","volume":"4","author":"Brandtzaeg","year":"2013","journal-title":"Benef. Microbes"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mib.2020.08.003","article-title":"Immunoglobulin A and the microbiome","volume":"56","author":"Yang","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2012.06538.x","article-title":"Zonulin, regulation of tight junctions, and autoimmune diseases","volume":"1258","author":"Fasano","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"16799","DOI":"10.1073\/pnas.0906773106","article-title":"Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2","volume":"106","author":"Tripathi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-59550-x","article-title":"The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study","volume":"10","author":"Horvath","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00394-019-02135-w","article-title":"Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: A randomized, double-blind, placebo-controlled pilot study","volume":"59","author":"Horvath","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Comas-Bast\u00e9, O., S\u00e1nchez-P\u00e9rez, S., Veciana-Nogu\u00e9s, M.T., Latorre-Moratalla, M., and Vidal-Carou, M.D.C. (2020). Histamine Intolerance: The Current State of the Art. Biomolecules, 10.","DOI":"10.3390\/biom10081181"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1002\/ibd.21588","article-title":"Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability","volume":"17","author":"Honzawa","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Laugerette, F., Vors, C., Alligier, M., Pineau, G., Drai, J., Knibbe, C., Morio, B., Lambert-Porcheron, S., Laville, M., and Vidal, H. (2020). Postprandial Endotoxin Transporters LBP and sCD14 Differ in Obese vs. Overweight and Normal Weight Men during Fat-Rich Meal Digestion. Nutrients, 12.","DOI":"10.3390\/nu12061820"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Tamaki, S., Kanazawa, A., Sato, J., Tamura, Y., Asahara, T., Takahashi, T., Matsumoto, S., Yamashiro, Y., and Watada, H. (2019). Clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes: A retrospective study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222598"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Liu, F., Lee, S.A., Riordan, S.M., Zhang, L., and Zhu, L. (2020). Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease. Front. Med., 7.","DOI":"10.3389\/fmed.2020.580803"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.3748\/wjg.v26.i28.4126","article-title":"Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation","volume":"26","author":"Dassopoulos","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"390230","DOI":"10.1155\/2015\/628157","article-title":"Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut","volume":"2015","author":"Michielan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"Salim","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000447252","article-title":"Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?","volume":"1","author":"Fukui","year":"2016","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/gut.2005.065557","article-title":"Genetic basis for increased intestinal permeability in families with Crohn\u2019s disease: Role of CARD15 3020insC mutation?","volume":"55","author":"Buhner","year":"2006","journal-title":"Gut"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1572-0241.2006.00928.x","article-title":"Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis","volume":"102","author":"Karlsen","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0483-8","article-title":"Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: Exploring a common ground hypothesis","volume":"25","author":"Yu","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00054725-199911000-00004","article-title":"Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora","volume":"5","author":"Madsen","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20050407","article-title":"The primary defect in experimental ileitis originates from a nonhematopoietic source","volume":"203","author":"Olson","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature05698","article-title":"Epithelial NEMO links innate immunity to chronic intestinal inflammation","volume":"446","author":"Nenci","year":"2007","journal-title":"Nature"},{"key":"ref_102","first-page":"G988","article-title":"Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis","volume":"309","author":"Nighot","year":"2015","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10620-012-2304-3","article-title":"Myosin Light Chain Kinase Inhibitor Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice","volume":"58","author":"Liu","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_104","first-page":"700","article-title":"NOD2-mediated dysbiosis pre-disposes mice to transmissible colitis and colorectal cancer","volume":"123","author":"Secher","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1053\/j.gastro.2018.02.019","article-title":"Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic \u03b3\u03b4 T-Cell Receptor\u2013Positive Cells and Pathogenesis of Cholestatic Liver Disease","volume":"154","author":"Tedesco","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_107","first-page":"1","article-title":"Associations of neopterin and kynurenine\u2013tryptophan ratio with survival in primary sclerosing cholangitis","volume":"2021","author":"Dhillon","year":"2021","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0168-8278(98)80058-5","article-title":"Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"29","author":"Sasatomi","year":"1998","journal-title":"J. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.3748\/wjg.v23.i29.5412","article-title":"Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis","volume":"23","author":"Tornai","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/00365520510023288","article-title":"Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis","volume":"40","author":"Cederborg","year":"2005","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/CCM.0b013e31828c26b5","article-title":"Enterocyte Damage in Critically Ill Patients Is Associated With Shock Condition and 28-Day Mortality","volume":"41","author":"Piton","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.12701\/yujm.2020.00703","article-title":"Pathophysiology and protective approaches of gut injury in critical illness","volume":"38","author":"Jung","year":"2021","journal-title":"Yeungnam Univ. J. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.surge.2012.03.003","article-title":"Gut-origin sepsis: Evolution of a concept","volume":"10","author":"Deitch","year":"2012","journal-title":"Surgeon"},{"key":"ref_114","first-page":"1","article-title":"NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients","volume":"7","author":"Stadlbauer","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Giordano, D.M., Pinto, C., Maroni, L., Benedetti, A., and Marzioni, M. (2018). Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103003"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/labinvest.2010.40","article-title":"Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation","volume":"90","author":"Haruta","year":"2010","journal-title":"Lab. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10620-006-9544-z","article-title":"Abnormal Intestinal Permeability in Primary Biliary Cirrhosis","volume":"51","author":"Feld","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00042737-200309000-00005","article-title":"Gastroduodenal and intestinal permeability in primary biliary cirrhosis","volume":"15","author":"Venturi","year":"2003","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08916930600623841","article-title":"Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis","volume":"39","author":"Haruta","year":"2006","journal-title":"Autoimmunity"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/00365521.2010.539624","article-title":"Altered biliary epithelial cell and monocyte responses to lipopolysac-charide as a TLR ligand in patients with primary biliary cirrhosis","volume":"46","author":"Zhao","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","article-title":"Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases","volume":"24","author":"Yang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Procopio, A.C., Fagoonee, S., Pellicano, R., Carbone, M., Luzza, F., and Invernizzi, P. (2020). Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists. Diseases, 8.","DOI":"10.3390\/diseases8020020"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000452300","article-title":"Bile Acids and the Potential Role in Primary Biliary Cirrhosis","volume":"94","author":"Yang","year":"2016","journal-title":"Digestion"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2015.12.007","article-title":"Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules","volume":"104","author":"Copple","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted Disruption of the Nuclear Receptor FXR\/BAR Impairs Bile Acid and Lipid Homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2020.06.006","article-title":"Intestinal microbiota-farnesoid X receptor axis in metabolic diseases","volume":"509","author":"Zou","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_127","first-page":"G554","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tips.2015.08.002","article-title":"TGR5 and Immunometabolism: Insights from Physiology and Pharmacology","volume":"36","author":"Perino","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Holter, M.M., Chirikjian, M.K., Govani, V.N., and Cummings, B.P. (2020). TGR5 Signaling in Hepatic Metabolic Health. Nutrients, 12.","DOI":"10.3390\/nu12092598"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3748\/wjg.v26.i40.6141","article-title":"Role of gut microbiota via the gut-liver-brain axis in digestive diseases","volume":"26","author":"Ding","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: Pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e13691","DOI":"10.1111\/nmo.13691","article-title":"High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitis","volume":"31","author":"Vincent","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2001.04668.x","article-title":"Small intestinal bacterial overgrowth in patients with cirrhosis: Prevalence and relation with spontaneous bacterial peritonitis","volume":"96","author":"Bauer","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jhep.2012.01.019","article-title":"Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease","volume":"56","author":"Fouts","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0025-6196(11)63734-8","article-title":"Bacterial and parasitic cholangitis","volume":"73","author":"Carpenter","year":"1998","journal-title":"Mayo. Clin. Proc."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/jcm.27.10.2373-2375.1989","article-title":"Aerobic and anaerobic microbiology of biliary tract disease","volume":"27","author":"Brook","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-1605(99)00025-2","article-title":"Effect of bacteriocin-producing lactobacilli on the survival of Escherichia coli and Listeria in a dynamic model of the stomach and the small intestine","volume":"48","author":"Hertel","year":"1999","journal-title":"Int. J. Food Microbiol."},{"key":"ref_142","first-page":"653","article-title":"The interaction of bile acids and Helicobacter pylori","volume":"34","author":"Hirai","year":"1999","journal-title":"J. Gastroenterol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Theriot, C.M., Bowman, A.A., and Young, V.B. (2016). Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine. mSphere, 1.","DOI":"10.1128\/mSphere.00045-15"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1194\/jlr.M039834","article-title":"Contribution of the 7\u03b2-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon","volume":"54","author":"Lee","year":"2013","journal-title":"J. Lipid. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jhep.2013.11.034","article-title":"Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity","volume":"60","author":"Vrieze","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Pereira, P., Aho, V., Arola, J., Boyd, S., Jokelainen, K., Paulin, L., Auvinen, P., and F\u00e4rkkil\u00e4, M. (2017). Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182924"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury\u2014What is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","article-title":"Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis","volume":"283","author":"Woolbright","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.3748\/wjg.v19.i33.5454","article-title":"Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis","volume":"19","author":"Gauss","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Mousa, O.Y., Juran, B.D., McCauley, B.M., Vesterhus, M.N., Folseraas, T., Turgeon, C.T., Ali, A.H., Schlicht, E.M., Atkinson, E.J., and Hu, C. (2020). Bile Acid Profiles in Primary Sclerosing Cholangitis and their Ability to Predict Hepatic Decompensation. Hepatology.","DOI":"10.1002\/hep.31652"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/liv.13092","article-title":"Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis","volume":"36","author":"Zweers","year":"2016","journal-title":"Liver Int."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Mouzaki, M., Wang, A.Y., Bandsma, R., Comelli, E.M., Arendt, B.M., Zhang, L., Fung, S., Fischer, S.E., McGilvray, I.G., and Allard, J.P. (2016). Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151829"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO3\u2212 umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3\u2212umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2011","journal-title":"Hepatology"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2012.02.014","article-title":"Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health","volume":"57","author":"Dilger","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis","volume":"58","author":"Chen","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/liv.14069","article-title":"Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus","volume":"39","author":"Hegade","year":"2019","journal-title":"Liver Int."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10096-016-2669-x","article-title":"Association of diverse bacterial communities in human bile samples with biliary tract disorders: A survey using culture and polymerase chain reaction-denaturing gradient gel electrophoresis methods","volume":"35","author":"Tajeddin","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-019-0712-8","article-title":"The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile","volume":"7","author":"Molinero","year":"2019","journal-title":"Microbiome"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jiph.2020.11.005","article-title":"Human bile microbiota: A retrospective study focusing on age and gender","volume":"14","author":"Serra","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1053\/j.gastro.2011.05.035","article-title":"Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation","volume":"141","author":"Steck","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-017-00796-x","article-title":"Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus","volume":"8","author":"Llorente","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jinf.2003.11.008","article-title":"Prosthetic valve endocarditis caused by Veillonella parvula","volume":"50","author":"Boo","year":"2005","journal-title":"J. Infect."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/clinids\/24.5.1013","article-title":"Prosthetic valve endocarditis due to Veillonella dispar: Successful medical treatment following penicillin desensitization","volume":"24","author":"Houston","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-4453(90)94197-8","article-title":"Endocarditis caused by Veillonella dispar","volume":"21","author":"Loughrey","year":"1990","journal-title":"J. Infect."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/PL00011273","article-title":"Prosthetic joint infection due to Veillonella dispar","volume":"20","author":"Marchandin","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/314046","article-title":"Veillonella parvula Meningitis: Case Report and Review of Veillonella Infections","volume":"31","author":"Bhatti","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/jgh.12694","article-title":"Association between specific mucosa-associated micro-biota in Crohn\u2019s disease at the time of resection and subsequent disease recurrence: A pilot study","volume":"30","author":"Kang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48352-5","article-title":"Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis","volume":"9","author":"Horvath","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2015.01.013","article-title":"Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis","volume":"70","author":"Leuchs","year":"2015","journal-title":"J. Infect."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"111036","DOI":"10.1016\/j.biopha.2020.111036","article-title":"The gut microbiome-bile acid axis in hepatocarcinogenesis","volume":"133","author":"Wu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.gastro.2020.08.054","article-title":"Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship with Acute-on-Chronic Liver Failure and Prognosis","volume":"160","author":"Guilly","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.3748\/wjg.v20.i40.14652","article-title":"Alcoholic disease: Liver and beyond","volume":"20","author":"Rocco","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nutres.2020.09.004","article-title":"Alcohol use alters the colonic mucosa\u2013associated gut microbiota in humans","volume":"83","author":"Gurwara","year":"2020","journal-title":"Nutr. Res."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Lebrun, E.S., Nighot, M., Dharmaprakash, V., Kumar, A., Lo, C.-C., Chain, P.S.G., and Ma, T.Y. (2020). The Gut Microbiome and Alcoholic Liver Disease: Ethanol Consumption Drives Consistent and Reproducible Alteration in Gut Microbiota in Mice. Life, 11.","DOI":"10.3390\/life11010007"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Stadlbauer, V., Horvath, A., Komarova, I., Schmerboeck, B., Feldbacher, N., Wurm, S., Klymiuk, I., Durdevic, M., Rainer, F., and Blesl, A. (2019). A single alcohol binge impacts on neu-trophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0211703"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/liv.14377","article-title":"Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis","volume":"40","author":"Lang","year":"2020","journal-title":"Liver Int."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-71939-2","article-title":"Compositional and functional differences of the mucosal microbiota along the intestine of healthy individuals","volume":"10","author":"Vaga","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: A review","volume":"26","author":"Little","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41598-020-57468-y","article-title":"Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome","volume":"10","author":"Sundin","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Yang, Q., Liang, Q., Balakrishnan, B., Belobrajdic, D.P., Feng, Q.-J., and Zhang, W. (2020). Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. Nutrients, 12.","DOI":"10.3390\/nu12020381"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Montes de Oca, A., Juli\u00e1n, M.T., Ramos, A., Puig-Domingo, M., and Alonso, N. (2020). Microbiota, Fiber, and NAFLD: Is There Any Connection?. Nutrients, 12.","DOI":"10.3390\/nu12103100"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Kummen, M., Thingholm, L.B., R\u00fchlemann, M.C., Holm, K., Hansen, S.H., Moitinho-Silva, L., Liwinski, T., Zenouzi, R., Storm-Larsen, C., and Midttun, \u00d8. (2020). Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis. Gastroenterology.","DOI":"10.1053\/j.gastro.2020.12.058"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12072-020-10089-z","article-title":"Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis","volume":"15","author":"Lapidot","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","article-title":"A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease with Bile Acid Pathways","volume":"14","author":"Quraishi","year":"2020","journal-title":"J. Crohns Colitis."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis","volume":"50","author":"Liwinski","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.13552","article-title":"The features of mucosa-associated microbiota in primary sclerosing cholangitis","volume":"43","author":"Torres","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","article-title":"Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis","volume":"10","author":"Kevans","year":"2016","journal-title":"J. Crohns Colitis."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","article-title":"The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II","volume":"9","author":"Rossen","year":"2015","journal-title":"J. Crohns Coliti"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1080\/00365521.2016.1216587","article-title":"The association between the gut microbiota and the inflammatory bowel disease activity: A systematic review and meta-analysis","volume":"51","author":"Prosberg","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Weinstein, N., Garten, B., Vainer, J., Minaya, D., and Czaja, K. (2020). Managing the Microbiome: How the Gut Influences Development and Disease. Nutrients, 13.","DOI":"10.3390\/nu13010074"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Kim, S.S., Eun, J.W., Cho, H.J., Song, D.S., Kim, C.W., Kim, Y.S., Lee, S.W., Kim, Y.-K., Yang, J., and Choi, J. (2020). Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis. Aliment. Pharmacol. Ther.","DOI":"10.1111\/apt.16200"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1785251","article-title":"Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients","volume":"12","author":"Lang","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Tang, Y., Zhou, H., Xiang, Y., and Cui, F. (2020). The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol.","DOI":"10.1097\/MEG.0000000000001978"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcmgh.2019.04.008","article-title":"Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome","volume":"8","author":"Sung","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/CVI.00310-09","article-title":"Receptor Recognition of and Immune Intracellular Pathways for Veillonella parvula Lipopolysaccharide","volume":"16","author":"Matera","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"104344","DOI":"10.1016\/j.micpath.2020.104344","article-title":"The critical role of Faecalibacterium prausnitzii in human health: An overview","volume":"149","author":"Leylabadlo","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"nzaa159","DOI":"10.1093\/cdn\/nzaa159","article-title":"Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium-Induced Colitis Model","volume":"4","author":"Lin","year":"2020","journal-title":"Curr. Dev. Nutr."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1136\/gutjnl-2012-303611","article-title":"Butyricicoccus pullicaecorum in inflammatory bowel disease","volume":"62","author":"Eeckhaut","year":"2013","journal-title":"Gut"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ecco-jcc\/jjw142","article-title":"Reduced Mucosa-associated Butyricicoccus Activity in Patients with Ulcerative Colitis Correlates with Aberrant Claudin-1 Expression","volume":"11","author":"Devriese","year":"2016","journal-title":"J. Crohns Coliti"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"27572","DOI":"10.1038\/srep27572","article-title":"Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/hepr.13509","article-title":"Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis","volume":"50","author":"Furukawa","year":"2020","journal-title":"Hepatol. Res."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Abe, K., Takahashi, A., Fujita, M., Imaizumi, H., Hayashi, M., Okai, K., and Ohira, H. (2018). Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198757"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","volume":"18","author":"Lv","year":"2016","journal-title":"Environ. Microbiol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-food-041715-033159","article-title":"Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health","volume":"7","author":"Joyce","year":"2016","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1053\/j.gastro.2020.06.100","article-title":"Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases","volume":"160","author":"Iliev","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","article-title":"Fungi in the healthy human gastrointestinal tract","volume":"8","author":"Suhr","year":"2017","journal-title":"Virulence"},{"key":"ref_225","first-page":"559","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"102950","DOI":"10.1016\/j.ebiom.2020.102950","article-title":"Gut mycobiome and its interaction with diet, gut bacteria and alzheimer\u2019s disease markers in subjects with mild cognitive impairment: A pilot study","volume":"59","author":"Nagpal","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3852\/15-147","article-title":"The human gut mycobiome: Pitfalls and potential\u2014A mycologist\u2019s perspective","volume":"107","author":"Suhr","year":"2015","journal-title":"Mycologia"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Gouba, N., Raoult, D., and Drancourt, M. (2013). Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059474"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1128\/JCM.01451-08","article-title":"Debaryomyces hansenii (Candida famata), a Rare Human Fungal Pathogen Often Misidentified as Pichia guilliermondii (Candida guilliermondii)","volume":"46","author":"Ragon","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","article-title":"The gut mycobiome of the Human Microbiome Project healthy cohort","volume":"5","author":"Nash","year":"2017","journal-title":"Microbiome"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G.D., Lewis, J.D., and Bushman, F.D. (2013). Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066019"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Matija\u0161i\u0107, M., Me\u0161trovi\u0107, T., Paljetak, H., Peri\u0107, M., Bare\u0161i\u0107, A., and Verbanac, D. (2020). Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082668"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Vesty, A., Biswas, K., Taylor, M.W., Gear, K., and Douglas, R.G. (2017). Evaluating the Impact of DNA Extraction Method on the Representation of Human Oral Bacterial and Fungal Communities. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169877"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/21505594.2016.1252015","article-title":"Mining the oral mycobiome: Methods, components, and meaning","volume":"8","author":"Diaz","year":"2016","journal-title":"Virulence"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-020-01740-5","article-title":"The gut mycobiome: A novel player in chronic liver diseases","volume":"56","author":"Jiang","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9560684","article-title":"Mycobiome in the Gut: A Multiperspective Review","volume":"2020","author":"Chin","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1128\/IAI.00449-12","article-title":"Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy","volume":"80","author":"Mason","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1038\/srep10416","article-title":"Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis","volume":"5","author":"Qiu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/IAI.67.1.302-307.1999","article-title":"Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa","volume":"67","author":"Castagliuolo","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1203\/01.pdr.0000220322.31940.29","article-title":"Saccharomyces boulardii Produces in Rat Small Intestine a Novel Protein Phosphatase that Inhibits Escherichia coli Endotoxin by Dephosphorylation","volume":"60","author":"Buts","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nri1745","article-title":"Dectin-1: A signalling non-TLR pattern-recognition receptor","volume":"6","author":"Brown","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.chom.2015.07.003","article-title":"Inhibition of Dectin-1 Signaling Ameliorates Colitis by Inducing Lactobacillus-Mediated Regulatory T Cell Expansion in the Intestine","volume":"18","author":"Tang","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1221789","article-title":"Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis","volume":"336","author":"Iliev","year":"2012","journal-title":"Science"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Beheshti-Maal, A., Shahrokh, S., Ansari, S., Mirsamadi, E.S., Yadegar, A., Mirjalali, H., and Zali, M.R. (2021). Gut mycobiome: The probable determinative role of fungi in IBD patients. Mycoses.","DOI":"10.1111\/myc.13238"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref_246","first-page":"1","article-title":"The gut mycobiota: Insights into analysis, environmental interactions and role in gastrointestinal diseases","volume":"16","author":"Richard","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","article-title":"Fungal microbiota dysbiosis in IBD","volume":"66","author":"Sokol","year":"2016","journal-title":"Gut"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13099-018-0258-5","article-title":"Identification of Schizosaccharomyces pombe in the guts of healthy individuals and patients with colorectal cancer: Preliminary evidence from a gut microbiome secretome study","volume":"10","author":"Chin","year":"2018","journal-title":"Gut Pathog."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1038\/srep07980","article-title":"Dysbiosis of Fungal Microbiota in the Intestinal Mucosa of Patients with Colorectal Adenomas","volume":"5","author":"Luan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1038\/srep14600","article-title":"Obesity changes the human gut myco-biome","volume":"5","author":"Esteve","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3920\/BM2017.0029","article-title":"The gut mycobiome composition is linked to carotid atherosclerosis","volume":"9","author":"Xifra","year":"2018","journal-title":"Benef. Microbes"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/PPA.S97852","article-title":"Higher diversity in fungal species discriminates children with type 1 diabetes mellitus from healthy control","volume":"10","author":"Zorena","year":"2016","journal-title":"Patient Prefer. Adherence"},{"key":"ref_253","first-page":"1","article-title":"The fecal mycobiome in patients with Irritable Bowel Syndrome","volume":"11","author":"Das","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.gastro.2017.06.004","article-title":"Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats","volume":"153","author":"Botschuijver","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MIB.0000000000000280","article-title":"Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn\u2019s disease","volume":"21","author":"Sivignon","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/gutjnl-2019-320008","article-title":"Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species","volume":"69","author":"Solovjeva","year":"2020","journal-title":"Gut"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt","year":"2013","journal-title":"Hepatology"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.4049\/jimmunol.1001153","article-title":"IL-23 and IL-17A, but Not IL-12 and IL-22, Are Required for Optimal Skin Host Defense against Candida albicans","volume":"185","author":"Kagami","year":"2010","journal-title":"J. Immunol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2011.10.018","article-title":"Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity","volume":"35","author":"Chen","year":"2011","journal-title":"Immunity"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2010.02.021","article-title":"Th17 and Regulatory T Cells in Mediating and Restraining Inflammation","volume":"140","author":"Littman","year":"2010","journal-title":"Cell"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and Type 17 Helper T Cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2006.07.022","article-title":"Biliary candida infections in primary sclerosing chol-angitis","volume":"45","author":"Kulaksiz","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1099\/jmm.0.008706-0","article-title":"Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis","volume":"58","author":"Oztas","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1099\/jmm.0.002188-0","article-title":"Liver cirrhosis caused by Exophiala dermatitidis","volume":"58","author":"Hong","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1128\/AEM.06331-11","article-title":"Diversity and Abundance of Single-Stranded DNA Viruses in Human Feces","volume":"77","author":"Kim","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"eaat9691","DOI":"10.1126\/science.aat9691","article-title":"Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection","volume":"363","author":"Sweere","year":"2019","journal-title":"Science"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Guerin, E., and Hill, C. (2020). Shining Light on Human Gut Bacteriophages. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00481"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.csbj.2020.11.055","article-title":"Gut eukaryotic virome in colorectal carcinogenesis: Is that a trigger?","volume":"19","author":"Massimino","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"10400","DOI":"10.1073\/pnas.1601060113","article-title":"Healthy human gut phageome","volume":"113","author":"Manrique","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/2050640619876787","article-title":"The gut virome in inflammatory bowel disease pathogenesis: From meta-genomics to novel therapeutic approaches","volume":"7","author":"Ungaro","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/19490976.2018.1511664","article-title":"Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease","volume":"10","author":"Ungaro","year":"2019","journal-title":"Gut Microbes"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm.3950","article-title":"Early life dynamics of the human gut virome and bacterial microbiome in infants","volume":"21","author":"Lim","year":"2015","journal-title":"Nat. Med."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.copbio.2020.09.016","article-title":"Phages to shape the gut microbiota?","volume":"68","author":"Dahlman","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Zhang, T., Breitbart, M., Lee, W.H., Run, J.-Q., Wei, C.L., Soh, S.W.L., Hibberd, M.L., Liu, E.T., Rohwer, F., and Ruan, Y. (2005). RNA Viral Community in Human Feces: Prevalence of Plant Pathogenic Viruses. PLoS Biol., 4.","DOI":"10.1371\/journal.pbio.0040003"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.chom.2020.10.007","article-title":"Putting the Virome on the Map: The Influence of Host Geography and Ethnicity on the Gut Virome","volume":"28","author":"Holtz","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12915-019-0704-y","article-title":"Studying the gut virome in the metagenomic era: Challenges and perspectives","volume":"17","author":"Garmaeva","year":"2019","journal-title":"BMC Biol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chom.2019.09.009","article-title":"The Human Gut Virome Is Highly Diverse, Stable, and Individual Specific","volume":"26","author":"Shkoporov","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.chom.2020.08.003","article-title":"The Gut Virome Database Reveals Age-Dependent Patterns of Virome Diversity in the Human Gut","volume":"28","author":"Gregory","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.chom.2020.08.005","article-title":"Human-Gut-DNA Virome Variations across Geography, Ethnicity, and Urbanization","volume":"28","author":"Zuo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1101\/gr.122705.111","article-title":"The human gut virome: Inter-individual variation and dynamic response to diet","volume":"21","author":"Minot","year":"2011","journal-title":"Genome Res."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","article-title":"Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis","volume":"25","author":"Gogokhia","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/gutjnl-2019-319809","article-title":"Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: The TEDDY study","volume":"69","author":"Lindfors","year":"2020","journal-title":"Gut"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/ctg.2013.7","article-title":"Human Enterovirus Species B in Ileocecal Crohn\u2019s Disease","volume":"4","author":"Berg","year":"2013","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.gastro.2018.04.018","article-title":"Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes","volume":"155","author":"Nakatsu","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/nm.4380","article-title":"The eukaryotic gut virome in hematopoietic stem cell transplantation: New clues in enteric graft-versus-host disease","volume":"23","author":"Legoff","year":"2017","journal-title":"Nat. Med."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.chom.2016.02.011","article-title":"Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome","volume":"19","author":"Monaco","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"11941","DOI":"10.1073\/pnas.1514285112","article-title":"Gut DNA viromes of Malawian twins discordant for severe acute malnutrition","volume":"112","author":"Reyes","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-018-0410-y","article-title":"A human gut phage catalog correlates the gut phageome with type 2 diabetes","volume":"6","author":"Ma","year":"2018","journal-title":"Microbiome"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"ofz025","DOI":"10.1093\/ofid\/ofz025","article-title":"Distinct Gut Virome Profile of Pregnant Women With Type 1 Diabetes in the ENDIA Study","volume":"6","author":"Wook","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2018-318131","article-title":"Gut mucosal virome alterations in ulcerative colitis","volume":"68","author":"Zuo","year":"2019","journal-title":"Gut"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"582187","DOI":"10.3389\/fcimb.2020.582187","article-title":"Virome Sequencing of the Human Intestinal Mucosal\u2013Luminal Interface","volume":"10","author":"Yan","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_294","first-page":"634","article-title":"Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome","volume":"67","author":"Zuo","year":"2018","journal-title":"Gut"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/19490976.2019.1586037","article-title":"The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: A retrospective cohort study","volume":"10","author":"Park","year":"2019","journal-title":"Gut Microbes"},{"key":"ref_296","first-page":"1","article-title":"Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.13100","article-title":"Long-term microbiota and virome in a Z\u00fcrich patient after fecal transplantation against Clostridium difficile infection","volume":"1372","author":"Broecker","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-018-0598-x","article-title":"Long-term colonisation with donor bacteriophages following successful faecal microbial transplantation","volume":"6","author":"Draper","year":"2018","journal-title":"Microbiome"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal Virome Signature Associated with Severity of Nonalcoholic Fatty Liver Disease","volume":"159","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal Virome in Patients with Alcoholic Hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Bajaj, J.S., Sikaroodi, M., Shamsaddini, A., Henseler, Z., Santiago-Rodriguez, T., Acharya, C., Fagan, A., Hylemon, P.B., Fuchs, M., and Gavis, E. (2020). Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy. Gut.","DOI":"10.1136\/gutjnl-2020-322470"},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Thijssen, M., Tacke, F., Beller, L., Deboutte, W., Yinda, K.C., Nevens, F., Laleman, W., Van Ranst, M., and Pourkarim, M.R. (2020). Clinical relevance of plasma virome dynamics in liver transplant recipients. EBioMedicine, 60.","DOI":"10.1016\/j.ebiom.2020.103009"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ajcn\/77.3.559","article-title":"Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans","volume":"77","author":"Letexier","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","article-title":"Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice","volume":"66","author":"Ferrere","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.1840200227","article-title":"Inactivation of Kupffer cells prevents early alcohol-induced liver injury","volume":"20","author":"Adachi","year":"1994","journal-title":"Hepatology"},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Horvath, A., Durdevic, M., Leber, B., di Vora, K., Rainer, F., Krones, E., Douschan, P., Spindelboeck, W., Durchschein, F., and Zollner, G. (2020). Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis. Nutrients, 12.","DOI":"10.3390\/nu12061874"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/apt.13788","article-title":"Randomised clinical trial: The effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis","volume":"44","author":"Horvath","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"6629196","DOI":"10.1155\/2020\/6629196","article-title":"Regulating Intestinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease","volume":"2020","author":"Chi","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","article-title":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: Randomized-controlled multicenter study","volume":"27","author":"Han","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","article-title":"Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis","volume":"48","author":"Stadlbauer","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/jn\/nxz088","article-title":"Lactobacillus reuteri ZJ617 Culture Supernatant Attenuates Acute Liver Injury Induced in Mice by Lipopolysaccharide","volume":"149","author":"Cui","year":"2019","journal-title":"J. Nutr."},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Ritze, Y., B\u00e1rdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., and Bischoff, S.C. (2014). Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0080169"},{"key":"ref_315","doi-asserted-by":"crossref","unstructured":"Bajaj, J.S., Heuman, D.M., Sanyal, A.J., Hylemon, P.B., Sterling, R.K., Stravitz, R.T., Fuchs, M., Ridlon, J.M., Daita, K., and Monteith, P. (2013). Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060042"},{"key":"ref_316","doi-asserted-by":"crossref","unstructured":"Caraceni, P., Vargas, V., Sol\u00e0, E., Alessandria, C., de Wit, K., Trebicka, J., Angeli, P., Mookerjee, R.P., Durand, F., and Pose, E. (2021). The use of Rifaximin in Patients with Cirrhosis. Hepatology.","DOI":"10.1002\/hep.31708"},{"key":"ref_317","doi-asserted-by":"crossref","unstructured":"Liu, Y., Fan, L., Cheng, Z., Yu, L., Cong, S., Hu, Y., Zhu, L., Zhang, B., Cheng, Y., and Zhao, P. (2021). Fecal transplantation alleviates acute liver injury in mice through regulating Treg\/Th17 cytokines balance. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-81263-y"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals with Steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nutres.2019.09.004","article-title":"Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration","volume":"71","author":"Safari","year":"2019","journal-title":"Nutr. Res."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4983","article-title":"Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation","volume":"243","author":"Sheng","year":"2017","journal-title":"J. Pathol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3945\/ajcn.116.131110","article-title":"Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction","volume":"105","author":"Louis","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3748\/wjg.v25.i4.509","article-title":"Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease","volume":"25","author":"Biolato","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_324","first-page":"G108","article-title":"FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection","volume":"317","author":"Cao","year":"2019","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","article-title":"Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse Model","volume":"25","author":"Hsu","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/hep.30055","article-title":"Gut-Liver Axis Beyond the Microbiome: How the Fungal Mycobiome Contributes to Alcoholic Liver Disease","volume":"68","author":"Szabo","year":"2018","journal-title":"Hepatology"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0039-1688501","article-title":"Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"39","author":"Shah","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: Vancomycin or metronidazole in patients with primary sclerosing cholangitis\u2014A pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term Treatment of Primary Sclerosing Cholangitis in Children with Oral Vancomycin: An Immunomodulating Antibiotic","volume":"47","author":"Davies","year":"2008","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_330","doi-asserted-by":"crossref","unstructured":"Howden, B.P., Smith, D.J., Mansell, A., Johnson, P.D.R., Ward, P.B., Stinear, T.P., and Davies, J.K. (2008). Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol., 8.","DOI":"10.1186\/1471-2180-8-39"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/MJT.0000000000000102","article-title":"Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis","volume":"24","author":"Tabibian","year":"2017","journal-title":"Am. J. Ther."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the Treatment of Patients with Primary Sclerosing Cholangitis: Results of a Pilot Study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: A randomized placebo-controlled crossover pilot study","volume":"20","author":"Vleggaar","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000338834","article-title":"Successful Treatment of Primary Sclerosing Cholangitis with a Steroid and a Probiotic","volume":"6","author":"Shimizu","year":"2012","journal-title":"Case Rep. Gastroenterol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/17474124.2019.1636647","article-title":"Pharmacologic management of primary sclerosing cholangitis: What\u2019s in the pipeline?","volume":"13","author":"Suri","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1194\/jlr.M005546","article-title":"Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR\/RXR-dependent and independent mechanisms","volume":"51","author":"Cai","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients with Primary Sclerosing Cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12072-020-10118-x","article-title":"Management of primary sclerosing cholangitis and its complications: An algorithmic approach","volume":"15","author":"Beuers","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4254\/wjh.v12.i8.423","article-title":"Review: Pathogenesis of cholestatic liver diseases","volume":"12","author":"Yokoda","year":"2020","journal-title":"World J. Hepatol."},{"key":"ref_343","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol., 67, 145\u2013172.","DOI":"10.1016\/j.jhep.2017.03.022"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/3\/1018\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:38:53Z","timestamp":1760161133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/3\/1018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,21]]},"references-count":343,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["nu13031018"],"URL":"https:\/\/doi.org\/10.3390\/nu13031018","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,21]]}}}